CLDX logo

Celldex Therapeutics (CLDX) Selling, general & administrative expenses

annual SGA:

$38.55M+$7.63M(+24.69%)
December 31, 2024

Summary

  • As of today (July 4, 2025), CLDX annual SGA is $38.55 million, with the most recent change of +$7.63 million (+24.69%) on December 31, 2024.
  • During the last 3 years, CLDX annual SGA has risen by +$18.06 million (+88.15%).
  • CLDX annual SGA is now at all-time high.

Performance

CLDX SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLDXincome statement metrics

quarterly SGA:

$10.82M+$557.00K(+5.43%)
March 31, 2025

Summary

  • As of today (July 4, 2025), CLDX quarterly SGA is $10.82 million, with the most recent change of +$557.00 thousand (+5.43%) on March 31, 2025.
  • Over the past year, CLDX quarterly SGA has increased by +$1.72 million (+18.86%).
  • CLDX quarterly SGA is now -9.30% below its all-time high of $11.93 million, reached on December 31, 2016.

Performance

CLDX quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLDXincome statement metrics

TTM SGA:

-$6.14B-$178.85M(-3.00%)
March 31, 2025

Summary

  • As of today (July 4, 2025), CLDX TTM SGA is -$6.14 billion, with the most recent change of -$178.85 million (-3.00%) on March 31, 2025.
  • Over the past year, CLDX TTM SGA has dropped by -$6.17 billion (-18491.07%).
  • CLDX TTM SGA is now -211568.52% below its all-time high of -$2.90 million.

Performance

CLDX TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLDXincome statement metrics

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

CLDX Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+24.7%+18.9%-10000.0%
3 y3 years+88.2%+56.6%-10000.0%
5 y5 years+149.9%+195.1%-10000.0%

CLDX Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+88.2%at high+65.7%-32.4%at low
5 y5-yearat high+166.7%at high+206.7%-50.5%at low
alltimeall timeat high+1928.8%-9.3%+345.0%<-9999.0%at low

CLDX Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Mar 2025
-
$10.82M(+5.4%)
$40.27M(+4.5%)
Dec 2024
$38.55M(+24.7%)
$10.26M(+2.1%)
$38.55M(+3.9%)
Sep 2024
-
$10.05M(+10.1%)
$37.12M(+5.2%)
Jun 2024
-
$9.13M(+0.3%)
$35.28M(+5.7%)
Mar 2024
-
$9.10M(+3.1%)
$33.38M(+8.0%)
Dec 2023
$30.91M(+13.7%)
$8.83M(+7.4%)
$30.91M(+7.8%)
Sep 2023
-
$8.22M(+13.8%)
$28.68M(+6.3%)
Jun 2023
-
$7.22M(+8.8%)
$26.99M(+0.2%)
Mar 2023
-
$6.64M(+0.6%)
$26.92M(-1.0%)
Dec 2022
$27.20M(+32.7%)
$6.60M(+1.0%)
$27.20M(+1.3%)
Sep 2022
-
$6.53M(-8.7%)
$26.84M(+2.7%)
Jun 2022
-
$7.15M(+3.5%)
$26.13M(+12.2%)
Mar 2022
-
$6.91M(+10.7%)
$23.28M(+13.6%)
Dec 2021
$20.49M(+41.7%)
$6.24M(+7.2%)
$20.49M(+14.6%)
Sep 2021
-
$5.82M(+35.2%)
$17.87M(+13.9%)
Jun 2021
-
$4.31M(+4.5%)
$15.69M(+5.2%)
Mar 2021
-
$4.12M(+13.7%)
$14.91M(+3.1%)
Dec 2020
$14.46M(-6.3%)
$3.62M(-0.5%)
$14.46M(+2.9%)
Sep 2020
-
$3.64M(+3.2%)
$14.05M(+1.7%)
Jun 2020
-
$3.53M(-3.8%)
$13.82M(-2.7%)
Mar 2020
-
$3.67M(+13.9%)
$14.20M(-8.0%)
Dec 2019
$15.43M(-19.9%)
$3.22M(-5.4%)
$15.43M(-6.7%)
Sep 2019
-
$3.40M(-12.9%)
$16.54M(-1.9%)
Jun 2019
-
$3.91M(-20.2%)
$16.86M(-9.2%)
Mar 2019
-
$4.90M(+13.0%)
$18.57M(-3.6%)
Dec 2018
$19.27M(-22.9%)
$4.33M(+16.4%)
$19.27M(-7.5%)
Sep 2018
-
$3.72M(-33.8%)
$20.83M(-7.2%)
Jun 2018
-
$5.62M(+0.5%)
$22.45M(-3.9%)
Mar 2018
-
$5.59M(-5.1%)
$23.37M(-6.5%)
Dec 2017
$25.00M(-30.5%)
$5.89M(+10.3%)
$25.00M(-19.4%)
Sep 2017
-
$5.35M(-18.2%)
$31.04M(-4.9%)
Jun 2017
-
$6.53M(-9.6%)
$32.64M(-3.7%)
Mar 2017
-
$7.23M(-39.4%)
$33.90M(-5.8%)
Dec 2016
$35.98M(+6.3%)
$11.93M(+71.7%)
$35.98M(+2.4%)
Sep 2016
-
$6.95M(-10.8%)
$35.12M(-4.2%)
Jun 2016
-
$7.79M(-16.3%)
$36.66M(-1.1%)
Mar 2016
-
$9.31M(-16.0%)
$37.05M(+9.5%)
Dec 2015
$33.84M(+64.1%)
$11.08M(+30.5%)
$33.84M(+16.6%)
Sep 2015
-
$8.49M(+3.7%)
$29.01M(+13.6%)
Jun 2015
-
$8.18M(+34.4%)
$25.53M(+15.4%)
Mar 2015
-
$6.09M(-2.6%)
$22.13M(+7.3%)
Dec 2014
$20.62M(+39.3%)
$6.25M(+24.9%)
$20.62M(+8.3%)
Sep 2014
-
$5.00M(+4.5%)
$19.05M(+8.1%)
Jun 2014
-
$4.79M(+4.5%)
$17.62M(+8.5%)
Mar 2014
-
$4.58M(-2.0%)
$16.25M(+9.8%)
Dec 2013
$14.80M(+47.8%)
$4.68M(+30.7%)
$14.80M(+15.9%)
Sep 2013
-
$3.58M(+4.9%)
$12.77M(+6.2%)
Jun 2013
-
$3.41M(+8.7%)
$12.03M(+11.0%)
Mar 2013
-
$3.14M(+18.7%)
$10.84M(+8.2%)
Dec 2012
$10.02M(+9.0%)
$2.64M(-6.7%)
$10.02M(+239.0%)
Sep 2012
-
$2.83M(+27.8%)
$2.95M(-37.3%)
Jun 2012
-
$2.22M(-4.2%)
$4.71M(-0.4%)
Mar 2012
-
$2.32M(-152.5%)
$4.73M(-0.4%)
Dec 2011
$9.19M(-11.4%)
-$4.42M(-196.2%)
$4.75M(-59.4%)
Sep 2011
-
$4.59M(+105.0%)
$11.70M(+22.8%)
Jun 2011
-
$2.24M(-4.1%)
$9.53M(-3.6%)
Mar 2011
-
$2.34M(-7.7%)
$9.88M(-4.8%)
Dec 2010
$10.38M(-39.4%)
$2.53M(+4.5%)
$10.38M(-27.3%)
Sep 2010
-
$2.42M(-6.6%)
$14.27M(-9.1%)
Jun 2010
-
$2.59M(-8.6%)
$15.69M(-5.5%)
Mar 2010
-
$2.83M(-55.8%)
$16.61M(-3.0%)
Dec 2009
$17.12M(+16.1%)
$6.42M(+66.7%)
$17.12M(+25.7%)
Sep 2009
-
$3.85M(+9.7%)
$13.62M(-2.5%)
Jun 2009
-
$3.51M(+5.1%)
$13.98M(-7.3%)
Mar 2009
-
$3.34M(+14.3%)
$15.08M(+2.1%)
Dec 2008
$14.75M(+113.6%)
$2.92M(-30.5%)
$14.77M(-0.7%)
Sep 2008
-
$4.21M(-8.7%)
$14.87M(+24.2%)
Jun 2008
-
$4.61M(+51.9%)
$11.97M(+42.3%)
Mar 2008
-
$3.03M(+0.4%)
$8.41M(+21.8%)
Dec 2007
$6.91M(-27.8%)
$3.02M(+131.4%)
$6.91M(-8.2%)
Sep 2007
-
$1.31M(+24.5%)
$7.52M(-6.4%)
Jun 2007
-
$1.05M(-31.3%)
$8.04M(-11.7%)
Mar 2007
-
$1.53M(-58.0%)
$9.10M(-4.8%)
DateAnnualQuarterlyTTM
Dec 2006
$9.56M(+38.7%)
$3.64M(+100.1%)
$9.56M(+26.2%)
Sep 2006
-
$1.82M(-14.1%)
$7.58M(+2.0%)
Jun 2006
-
$2.12M(+6.5%)
$7.43M(+3.6%)
Mar 2006
-
$1.99M(+20.3%)
$7.17M(+4.0%)
Dec 2005
$6.89M(+23.7%)
$1.65M(-1.0%)
$6.89M(-1.0%)
Sep 2005
-
$1.67M(-10.3%)
$6.96M(+5.8%)
Jun 2005
-
$1.86M(+8.8%)
$6.58M(+9.9%)
Mar 2005
-
$1.71M(-0.5%)
$5.99M(+7.5%)
Dec 2004
$5.57M(+4.1%)
$1.72M(+33.2%)
$5.57M(+7.1%)
Sep 2004
-
$1.29M(+1.6%)
$5.20M(-2.5%)
Jun 2004
-
$1.27M(-1.7%)
$5.34M(-1.5%)
Mar 2004
-
$1.29M(-4.3%)
$5.42M(+1.3%)
Dec 2003
$5.35M(-4.3%)
$1.35M(-5.1%)
$5.35M(-0.8%)
Sep 2003
-
$1.42M(+5.3%)
$5.39M(+1.9%)
Jun 2003
-
$1.35M(+10.4%)
$5.30M(-6.0%)
Mar 2003
-
$1.22M(-12.1%)
$5.63M(+0.7%)
Dec 2002
$5.59M(+13.8%)
$1.39M(+5.1%)
$5.59M(+2.3%)
Sep 2002
-
$1.33M(-21.4%)
$5.46M(+0.1%)
Jun 2002
-
$1.69M(+42.3%)
$5.46M(+10.1%)
Mar 2002
-
$1.19M(-6.3%)
$4.96M(-0.6%)
Dec 2001
$4.91M(+2.2%)
$1.27M(-4.3%)
$4.99M(-6.5%)
Sep 2001
-
$1.32M(+11.2%)
$5.34M(+5.4%)
Jun 2001
-
$1.19M(-2.1%)
$5.07M(+3.0%)
Mar 2001
-
$1.21M(-24.7%)
$4.92M(+2.3%)
Dec 2000
$4.81M(+12.3%)
$1.61M(+53.6%)
$4.81M(+0.7%)
Sep 2000
-
$1.05M(+0.8%)
$4.78M(+5.5%)
Jun 2000
-
$1.04M(-5.5%)
$4.52M(+0.9%)
Mar 2000
-
$1.10M(-30.2%)
$4.48M(+2.3%)
Dec 1999
$4.28M(+12.6%)
$1.58M(+97.5%)
$4.38M(+4.3%)
Sep 1999
-
$800.00K(-20.0%)
$4.20M(-2.3%)
Jun 1999
-
$1.00M(0.0%)
$4.30M(+7.5%)
Mar 1999
-
$1.00M(-28.6%)
$4.00M(+8.1%)
Dec 1998
$3.80M(+8.6%)
$1.40M(+55.6%)
$3.70M(+19.4%)
Sep 1998
-
$900.00K(+28.6%)
$3.10M(0.0%)
Jun 1998
-
$700.00K(0.0%)
$3.10M(-11.4%)
Mar 1998
-
$700.00K(-12.5%)
$3.50M(-2.8%)
Dec 1997
$3.50M(-46.2%)
$800.00K(-11.1%)
$3.60M(-14.3%)
Sep 1997
-
$900.00K(-18.2%)
$4.20M(0.0%)
Jun 1997
-
$1.10M(+37.5%)
$4.20M(-33.3%)
Mar 1997
-
$800.00K(-42.9%)
$6.30M(-3.1%)
Dec 1996
$6.50M(+10.2%)
$1.40M(+55.6%)
$6.50M(-3.0%)
Sep 1996
-
$900.00K(-71.9%)
$6.70M(-9.5%)
Jun 1996
-
$3.20M(+220.0%)
$7.40M(+34.5%)
Mar 1996
-
$1.00M(-37.5%)
$5.50M(-6.8%)
Dec 1995
$5.90M(+1.7%)
$1.60M(0.0%)
$5.90M(+5.4%)
Sep 1995
-
$1.60M(+23.1%)
$5.60M(+5.7%)
Jun 1995
-
$1.30M(-7.1%)
$5.30M(-7.0%)
Mar 1995
-
$1.40M(+7.7%)
$5.70M(-1.7%)
Dec 1994
$5.80M(-63.7%)
$1.30M(0.0%)
$5.80M(-30.1%)
Sep 1994
-
$1.30M(-23.5%)
$8.30M(-25.9%)
Jun 1994
-
$1.70M(+13.3%)
$11.20M(-17.6%)
Mar 1994
-
$1.50M(-60.5%)
$13.60M(-15.0%)
Dec 1993
$16.00M(+58.4%)
$3.80M(-9.5%)
$16.00M(+31.1%)
Sep 1993
-
$4.20M(+2.4%)
$12.20M(+2.5%)
Jun 1993
-
$4.10M(+5.1%)
$11.90M(+6.3%)
Mar 1993
-
$3.90M(0.0%)
$11.20M(-23.8%)
Dec 1992
$10.10M(-26.3%)
-
-
Oct 1992
-
$3.90M(+14.7%)
$14.70M(+4.3%)
Jul 1992
-
$3.40M(-12.8%)
$14.10M(+2.9%)
Apr 1992
-
$3.90M(+11.4%)
$13.70M(+5.4%)
Apr 1992
$13.70M(+6.2%)
-
-
Jan 1992
-
$3.50M(+6.1%)
$13.00M(+2.4%)
Oct 1991
-
$3.30M(+10.0%)
$12.70M(+0.8%)
Jul 1991
-
$3.00M(-6.3%)
$12.60M(-2.3%)
Apr 1991
$12.90M(+12.2%)
$3.20M(0.0%)
$12.90M(+1.6%)
Jan 1991
-
$3.20M(0.0%)
$12.70M(-0.8%)
Oct 1990
-
$3.20M(-3.0%)
$12.80M(+33.3%)
Jul 1990
-
$3.30M(+10.0%)
$9.60M(+52.4%)
Apr 1990
$11.50M(+38.6%)
$3.00M(-9.1%)
$6.30M(+90.9%)
Jan 1990
-
$3.30M
$3.30M
Apr 1989
$8.30M(+36.1%)
-
-
Apr 1988
$6.10M(+64.9%)
-
-
Apr 1987
$3.70M(+94.7%)
-
-
Apr 1986
$1.90M
-
-

FAQ

  • What is Celldex Therapeutics annual SGA?
  • What is the all time high annual SGA for Celldex Therapeutics?
  • What is Celldex Therapeutics annual SGA year-on-year change?
  • What is Celldex Therapeutics quarterly SGA?
  • What is the all time high quarterly SGA for Celldex Therapeutics?
  • What is Celldex Therapeutics quarterly SGA year-on-year change?
  • What is Celldex Therapeutics TTM SGA?
  • What is the all time high TTM SGA for Celldex Therapeutics?
  • What is Celldex Therapeutics TTM SGA year-on-year change?

What is Celldex Therapeutics annual SGA?

The current annual SGA of CLDX is $38.55M

What is the all time high annual SGA for Celldex Therapeutics?

Celldex Therapeutics all-time high annual SGA is $38.55M

What is Celldex Therapeutics annual SGA year-on-year change?

Over the past year, CLDX annual SGA has changed by +$7.63M (+24.69%)

What is Celldex Therapeutics quarterly SGA?

The current quarterly SGA of CLDX is $10.82M

What is the all time high quarterly SGA for Celldex Therapeutics?

Celldex Therapeutics all-time high quarterly SGA is $11.93M

What is Celldex Therapeutics quarterly SGA year-on-year change?

Over the past year, CLDX quarterly SGA has changed by +$1.72M (+18.86%)

What is Celldex Therapeutics TTM SGA?

The current TTM SGA of CLDX is -$6.14B

What is the all time high TTM SGA for Celldex Therapeutics?

Celldex Therapeutics all-time high TTM SGA is -$2.90M

What is Celldex Therapeutics TTM SGA year-on-year change?

Over the past year, CLDX TTM SGA has changed by -$6.17B (-18491.07%)
On this page